Shares of Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $7.9152, but opened at $8.40. Oxford BioMedica shares last traded at $8.44, with a volume of 26,300 shares traded.
Oxford BioMedica Trading Up 6.6%
The stock’s 50-day simple moving average is $8.10 and its 200 day simple moving average is $9.00.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Featured Stories
- Five stocks we like better than Oxford BioMedica
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
- The J.M. Smucker Company’s Dividend: Too Sweet to Ignore?
- From Crypto to AI: Insiders Are Trading These 3 Stocks
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
